Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Journal of Neuro-Oncology
|
June 6, 2018
Rethinking medulloblastoma from a targeted therapeutics perspective
Yuuri Hashimoto, Marta Penas-Prado, Shouhao Zhou, et al.
Communications Medicine
|
August 1, 2025
Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer
Yating Cheng, Norsang Lama, Ming Chen, et al.
BMC Cancer
|
October 18, 2023
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing
Misako Nagasaka, Shannon S Zhang, Yasmine Baca, et al.
Communications Medicine
|
October 24, 2025
Author Correction: Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer
Yating Cheng, Norsang Lama, Ming Chen, et al.
Translational Oncology
|
January 19, 2021
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type
Jim Abraham, Amy B Heimberger, John Marshall, et al.
Research Square
|
January 18, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
Midhun Malla, Sachin Kumar Deshkmukh, Sharon Wu, et al.
Neuro-Oncology
|
July 3, 2016
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
Sarah T Garber, Yuuri Hashimoto, Shiao-Pei Weathers, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens
Jonas Fischer, Katherine H Shutta, Chen Chen, et al.
Journal of Neuro-Oncology
|
May 31, 2018
Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design
Richard G Everson, Yuuri Hashimoto, Jacob L Freeman, et al.
British Journal of Cancer
|
September 3, 2024
Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors
Saikat Chowdhury, Joanne Xiu, Jennifer R Ribeiro, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Journal of Neuro-Oncology
|
June 6, 2018
Rethinking medulloblastoma from a targeted therapeutics perspective
Yuuri Hashimoto, Marta Penas-Prado, Shouhao Zhou, et al.
Communications Medicine
|
August 1, 2025
Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer
Yating Cheng, Norsang Lama, Ming Chen, et al.
BMC Cancer
|
October 18, 2023
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing
Misako Nagasaka, Shannon S Zhang, Yasmine Baca, et al.
Communications Medicine
|
October 24, 2025
Author Correction: Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer
Yating Cheng, Norsang Lama, Ming Chen, et al.
Translational Oncology
|
January 19, 2021
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type
Jim Abraham, Amy B Heimberger, John Marshall, et al.
Research Square
|
January 18, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
Midhun Malla, Sachin Kumar Deshkmukh, Sharon Wu, et al.
Neuro-Oncology
|
July 3, 2016
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
Sarah T Garber, Yuuri Hashimoto, Shiao-Pei Weathers, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens
Jonas Fischer, Katherine H Shutta, Chen Chen, et al.
Journal of Neuro-Oncology
|
May 31, 2018
Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design
Richard G Everson, Yuuri Hashimoto, Jacob L Freeman, et al.
British Journal of Cancer
|
September 3, 2024
Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors
Saikat Chowdhury, Joanne Xiu, Jennifer R Ribeiro, et al.
Page
of 9